| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662257 | International Journal of Cardiology | 2018 | 7 Pages |
Abstract
LCZ696 attenuated adverse cardiac remodeling and dysfunction and reduced pulmonary congestion and hypertrophic markers after MI compared to perindopril. This study supports clinical evaluation of ARNi versus ACEi in targeting post-MI cardiac dysfunction and remodeling.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew R. Kompa, Jiayu Lu, Thomas J. Weller, Darren J. Kelly, Henry Krum, Thomas G. von Lueder, Bing H. Wang,